Clinical Trials Logo

Anesthesia, Conduction clinical trials

View clinical trials related to Anesthesia, Conduction.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03718377 Recruiting - Pain Management Clinical Trials

The Effects of Ultrasound-guided Serratus Plane Block During Video-assisted Thoracoscopic Lobectomy

Start date: August 28, 2018
Phase: N/A
Study type: Interventional

This study evaluates the effects of serratus plane block on intraoperative opioid consumption, emergence time and hemodynamic stability in patients undergoing video-assisted thoracic surgery.

NCT ID: NCT03488888 Recruiting - Analgesia Clinical Trials

PEC Block II in Mammoplasty Surgeries

Start date: November 3, 2017
Phase: N/A
Study type: Interventional

Breast augmentation surgery is the top cosmetic surgery in USA with more then 300.000 cases performed annually. Pain is a common complications of the procedure accompanied of dyspnea and nausea due to the surgical manipulation. Several anesthetic techniques were developed with the objective of providing optimal surgical conditions together with enhanced recovery and post-op pain management. Pectoralis major block was first described in 2011 by Blanco in female patients undergoing oncologic procedures in the anterior thoracic wall. The investigators hypothesized if the Pectoralis Major block combined with general anesthesia standard techniques could be beneficial in improving pain scores and opioid consumption during post operative period of patients undergoing breast augmentation surgery.

NCT ID: NCT03181438 Recruiting - Clinical trials for Kidney Transplantation

Efficacy Transverse Abdominal Plane (TAP) Block Renal Transplant Surgery

Start date: June 3, 2017
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the efficacy and safety of transverse abdominal plane block in patients undergoing renal transplant surgery.Adult renal transplant recipients will be prospectively randomized to receive a standard general anesthetic technique supplemented with ropivacaine 0.375% 20 mL TAP block or sham block with 20 mL 0.9% saline. Both groups will receive patient-controlled morphine analgesia. Patient assessment will occur in the postanesthetic care unit and at 1, 2, 4, 6, 12, and 24 hours. The primary outcome is total morphine consumption in the first 24 hours after renal transplantation. Other outcomes asses include pain scores, presence of nausea or vomiting, excessive sedation, and respiratory depression.